Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00362609
What this trial is testing

Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD

Who this might be right for
Gastroesophageal Reflux
Wyeth is now a wholly owned subsidiary of Pfizer 59
Early research (Phase 1)Study completedNCT03083704
What this trial is testing

A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa

Who this might be right for
Bleeding
Portola Pharmaceuticals 153
Early research (Phase 1)Study completedNCT03093714
What this trial is testing

Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects

Who this might be right for
Cystic Fibrosis
Flatley Discovery Lab LLC 27
Testing effectiveness (Phase 2)Study completedNCT06542614
What this trial is testing

Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 209
Early research (Phase 1)Study completedNCT00064584
What this trial is testing

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Millennium Pharmaceuticals, Inc. 60
Early research (Phase 1)Study completedNCT04975022
What this trial is testing

A Study Evaluating the Bioavailability of Oral Insulin (N11005)

Who this might be right for
PK, PD, and Safety
Beijing Hospital 12
Testing effectiveness (Phase 2)Study completedNCT01146522
What this trial is testing

Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia

Who this might be right for
Hyperlipoproteinemia
Novartis Pharmaceuticals 8
Early research (Phase 1)WithdrawnNCT01090570
What this trial is testing

Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving Methotrexate

Who this might be right for
Rheumatoid Arthritis
Plexxikon
Early research (Phase 1)Study completedNCT02829541
What this trial is testing

A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participants

Who this might be right for
Systemic Lupos Erythematosus, SLE
Biogen 36
Early research (Phase 1)Study completedNCT01979601
What this trial is testing

Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Novartis Pharmaceuticals 74
Testing effectiveness (Phase 2)Study completedNCT01947907
What this trial is testing

Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

Who this might be right for
Growth Hormone Deficiency (GHD)
Ascendis Pharma A/S 53
Early research (Phase 1)Study completedNCT03769831
What this trial is testing

The PK/PD Study of SHR2285 Tablets in Healthy Subjects

Who this might be right for
Thrombosis
Jiangsu HengRui Medicine Co., Ltd. 28
Early research (Phase 1)Study completedNCT05184322
What this trial is testing

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Who this might be right for
ObesityType 2 Diabetes Mellitus
Sciwind Biosciences APAC CO Pty. Ltd. 87
Early research (Phase 1)Study completedNCT06181370
What this trial is testing

Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF

Who this might be right for
IPF
Agomab Spain S.L. 143
Early research (Phase 1)Study completedNCT02037074
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics

Who this might be right for
Schizophrenia
FORUM Pharmaceuticals Inc 40
Early research (Phase 1)Looking for participantsNCT07323173
What this trial is testing

Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Nanjing Leads Biolabs Co.,Ltd 117
Large-scale testing (Phase 3)Looking for participantsNCT07188805
What this trial is testing

Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

Who this might be right for
Left Ventricular Systolic DysfunctionHeart Failure (Pediatric)
Bayer 111
Testing effectiveness (Phase 2)Study completedNCT03025542
What this trial is testing

Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 49
Testing effectiveness (Phase 2)Study completedNCT04305197
What this trial is testing

ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Beijing InnoCare Pharma Tech Co., Ltd. 60
Very early researchUnknownNCT05800041
What this trial is testing

A Exploratory Trial of WTX221 in Refractory Gout Patients

Who this might be right for
Gout Tophus
RenJi Hospital 7
Next Page